News

The impact of diabetes on cardiovascular health remains one of the most urgent clinical challenges, influencing outcomes for millions worldwide.

The management of persons living with MASLD requires interdisciplinary collaboration to minimise long-term risks and improve patient outcomes.

Obesity is becoming increasingly common among people with type 1 diabetes (T1D), and vice versa.

Inspiring the next generation in diabetes care

A new era for diabetes technology training

Harmonising recommendations on the management of hyperglycaemic crises

In 1974, the International Society for Pediatric and Adolescent Diabetes (ISPAD) was founded as a professional organisation to promote science, research, education and advocacy in childhood and adolescent di...

Cardiologists are increasingly interested in advances in diabetology, especially the latest drug classes, reports Tina Vilsbøll from a joint session of the European Association for the Study of Diabet...

The global burden of diabetes is continually growing, which calls for enhanced collective action to prevent and treat diabetes complications. The Sri Lanka College of Endocrinology, the European Association ...

People living with diabetes have to make hundreds of decisions each day to manage their disease. Diabetes technology promises to ease this burden, but how effective is it in practice? This was one of the que...

While obesity is regarded a major risk factor for the development of type 2 diabetes, the causality of the association remains debated. With current therapies targeting both obesity and diabetes, the exchang...

More than half of all men with diabetes have impaired sexual health, most commonly due to erectile dysfunction. In women with diabetes, sexual dysfunction is less prevalent, but still occurs. In a joint sess...

‘Epidemiologic trends and disparities in diabetes risk factors among LGBTQ+ populations’ was the title of a presentation at the 59th Annual Meeting of the EASD and it highlighted the need for mor...

There is increasing interest in the role of the microbiome in many areas of medicine, including diabetes, in the hope of discovering novel therapeutic applications. A symposium at the 59th Annual Meeting of ...

Recent research suggests that there is much more to obesity than elevated body mass index. The latest findings on the role of liver fat and metabolically healthy obesity were under discussion at the 59th Ann...

The benefits of SGLT-2 inhibitors for people with type 2 diabetes and chronic kidney disease (CKD) have been amply demonstrated in recent years. So is it time to prescribe them to all those who have both con...

The latest research into hypoglycaemia was under discussion at the 59th Annual Meeting of the EASD. The ‘To hell with the hypo’ session covered topics ranging from a tool to predict nocturnal hyp...

Disparities in health burdens were explored at the American Diabetes Association’s 83rd Scientific Sessions. Lisa Buckingham reports. 

What are the barriers to technology use in primary care and how can we overcome them? This question was addressed at the American Diabetes Association’s 83rd Scientific Sessions. Lisa Buckingham report...

As research increasingly focuses on the early stages of type 1 diabetes, a presentation at the American Diabetes Association’s 83rd Scientific Sessions covered the emerging data on the potential of phy...

Intermittent fasting (IF) has gained popularity as a way of losing weight and improving cardiometabolic health. A debate on whether the window for eating within an IF regime is best timed early or late in th...